| Authors: |
Mzava O; Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, United States., Agun GF; Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, United States., Loy CJ; Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, United States., Gonzalez-Bocco IH; Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA, United States.; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, United States., Djomnang Kounatse LA; Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, United States., Bliss A; Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, United States., Wells SL; Division of Renal Medicine, Brigham and Women's Hospital, Boston, MA, United States.; Adult Survivorship Program, Dana Farber Cancer Institute, Boston, MA, United States., Lenz J; Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, United States., Belcher E; Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, United States., Chen K; Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA, United States., Koo S; Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States., Baden LR; Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States., Chu T; Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, United States., Cheng MP; Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA, United States.; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, United States., Ritz J; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States., Gupta S; Division of Renal Medicine, Brigham and Women's Hospital, Boston, MA, United States.; Adult Survivorship Program, Dana Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States., De Vlaminck I; Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, United States. |
